Pimocard 2.5 mg Flavoured Tablets for Dogs
Pimocard 2.5 mg Flavoured Tablets for Dogs
Authorised
- Pimobendan
Product identification
Medicine name:
Pimocard 2.5 mg Flavoured Tablets for Dogs
Pimocard 2,5 mg aromatizētas tabletes suņiem
Active substance:
- Pimobendan
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Pimobendan2.50milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Withdrawal period by route of administration:
-
Oral use
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QC01CE90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Latvia
Package description:
- 5 Aluminium-aluminium blisters with 10 tablets per blister in a carton box.
- 2 Aluminium-PVC/PE/PVDC blisters with 10 tablets per blister in a carton box.
- 5 Aluminium-PVC/PE/PVDC blisters with 10 tablets per blister in a carton box.
- 25 Aluminium-aluminium blisters with 10 tablets per blister in a carton box.
- 25 Aluminium-PVC/PE/PVDC blisters with 10 tablets per blister in a carton box.
- 2 Aluminium-aluminium blisters with 10 tablets per blister in a carton box.
- 10 Aluminium-aluminium blisters with 10 tablets per blister in a carton box.
- 10 Aluminium-PVC/PE/PVDC blisters with 10 tablets per blister in a carton box.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Eurovet Animal Health B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Dales Pharmaceuticals Limited
- Eurovet Animal Health B.V.
- Genera d.d.
Responsible authority:
- Food And Veterinary Service
Authorisation number:
- V/MRP/15/0061
Date of authorisation status change:
Reference member state:
-
Netherlands
Procedure number:
- NL/V/0283/002
Concerned member states:
-
Belgium
-
Bulgaria
-
Croatia
-
Cyprus
-
Czechia
-
Estonia
-
Germany
-
Hungary
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Latvian (PDF)
Published on: 17/07/2024
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Latvian (PDF)
Published on: 17/07/2024
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Latvian (PDF)
Published on: 17/07/2024
How useful was this page?: